Toxins News and Research

RSS

Ban smoking in cars urges BMA

The British Medical Association is calling for a ban on smoking in all cars. The BMA says research shows levels of toxins in a car after a cigarette has been smoked are up to 23 times higher than they would be in a smoky bar.

17 Nov 2011

The story of E. coli

It has been the cause of infamous international foodborne disease outbreaks and yet it is the most studied bacterium in science, an essential part of the human digestive tract, and a backbone of the biotech industry.

16 Nov 2011

Faster, more sensitive test to detect ciguatera poisoning

Scientists are reporting development of a fast, reliable new test that could help people avoid a terrible type of food poisoning that comes from eating fish tainted with a difficult-to-detect toxin from marine algae growing in warm waters. The report appears in ACS' journal Analytical Chemistry.

10 Nov 2011

Potential fish enzyme biomarker for environmental toxins

The level of the enzyme carbonyl reductase (CBR) is elevated in the livers of fish that have been exposed to cleaned wastewater. Scientists at the University of Gothenburg can show that CBR has properties that may make it suitable to be used as a biomarker, an early warning signal of environmental toxins. The aim of the project is to achieve better environmental monitoring.

9 Nov 2011

The Kresge Foundation to support two HIAs to inform housing sector decisions

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, announced today that The Kresge Foundation will support two health impact assessments (HIAs) to inform decisions in the housing sector.

8 Nov 2011

CWRU to establish umbrella program for integrative oncology

Case Western Reserve University School of Medicine is honored to announce gifts to establish the inaugural Parker Hannifin - Helen Moss Cancer Research Foundation Professorship in Integrative Oncology. This professorship will establish the School of Medicine and its affiliate hospitals as national leaders in teaching, research, and patient care in the field of integrative oncology.

8 Nov 2011

New technology can detect toxins in a person's breath

Breathing. Anyone reading this article is doing it right now. But what chemicals are we breathing in, and out? A group of Virginia Tech College of Engineering researchers has published a paper in the journal Environmental Science & Technology that details how to learn just that, using microelectromechanical systems to focus on toxins and everyday impurities that enter the body through the air we intake.

8 Nov 2011

Gifts established at Case Western Reserve to educate physicians in integrative oncology

7 Nov 2011

Patients with lupus nephritis ESRD choose hemodialysis as initial therapy

Newly published research shows that more patients with end-stage renal disease (ESRD) caused by lupus nephritis choose hemodialysis as their initial kidney replacement therapy over peritoneal dialysis and preemptive kidney transplantation.

7 Nov 2011

Azantis introduces reduced glutathione and vitamin C liposomal products

Azantis launched today two innovative liposomal products: reduced glutathione and vitamin C. Both oral supplements are formulated in liposomal form to maximize absorption and to minimize side effects. Azantis, a leading phospholipid manufacturer, markets the liposomal products to resellers targeting the health care practitioner channel.

1 Nov 2011

Researcher's compound disables bacteria instead of killing them

After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval. A microbiologist at the University of Wisconsin-Milwaukee (UWM) has discovered a different approach: Instead of killing the bacteria, why not disarm them, quashing disease without the worry of antibiotic resistance?

29 Oct 2011

Study: Reduced secretion of beta-amyloid signals beginning of Alzheimer's

For decades the amyloid hypothesis has dominated the research field in Alzheimer's disease. The theory describes how an increase in secreted beta-amyloid peptides leads to the formation of plaques, toxic clusters of damaged proteins between cells, which eventually result in neurodegeneration. Scientists at Lund University, Sweden, have now presented a study that turns this premise on its head.

29 Oct 2011

NK cells can fight against anthrax

One of the things that makes inhalational anthrax so worrisome for biodefense experts is how quickly a relatively small number of inhaled anthrax spores can turn into a lethal infection. By the time an anthrax victim realizes he or she has something worse than the flu and seeks treatment, it's often too late; even the most powerful antibiotics may be no help against the spreading bacteria and the potent toxins they generate.

28 Oct 2011

Bisphenol A can affect newborns' cholinergic signal system

Newborn mice that are exposed to Bisphenol A develop changes in their spontaneous behavior and evince poorer adaptation to new environments, as well hyperactivity as young adults. This has been shown by researchers at Uppsala University. Their study also revealed that one of the brain's most important signal systems, the cholinergic signal system, is affected by Bisphenol A and that the effect persisted into adulthood.

27 Oct 2011

Ipsen, Syntaxin collaborate to develop new botulinum toxins

Ipsen and Syntaxin, a biotechnology company specialising in innovative biopharmaceutical therapies targeting cell secretion pathways, announced today a global strategic collaboration to explore the discovery and development of new compounds in the field of botulinum toxins.

20 Oct 2011

Four companies receive NIAID contracts to develop broad-spectrum therapeutics

Four companies are to develop broad-spectrum therapeutics-antibiotics, antivirals and an antitoxin-to prevent or treat diseases caused by multiple types of bacteria or viruses, under contracts awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

14 Oct 2011

Scientists reprogram skin cells of patients with mental disorders into brain cells

For many poorly understood mental disorders, such as schizophrenia or autism, scientists have wished they could uncover what goes wrong inside the brain before damage ensues.

13 Oct 2011

HHS: Pica eating disorder hospitalizations on the rise in the U.S.

An unusual eating disorder that many people have never even heard of is attracting attention because of a recent government study that indicated the disorder is on the rise in the United States.

13 Oct 2011

Antivirulence drugs may fight infection and suppress resistance

Antivirulence drugs disarm pathogens rather than kill them, and although they could be effective in theory, antivirulence drugs have never been tested in humans. A new study to be published in the online journal mBio- on Tuesday, October 18 reveals these drugs have the potential to fight infection while avoiding the pitfalls of drug resistance.

11 Oct 2011

University of Leicester's public lectures to explore reality of toxic damage

The genetic and biochemical consequences of exposure to toxins and mutagens are the theme of the next in a series of accessible lecture events at the University of Leicester.

7 Oct 2011